|
Sign In to gain access to subscriptions and/or personal tools.
|
Lipid Signaling and Synaptic Plasticity
Nan Sang
Neuroscience Center of Excellence; School of Medicine, Louisiana State University Health Sciences Center, New Orleans
Chu Chen
Neuroscience Center of Excellence; Department of Otorhinolaryngology School of Medicine, Louisiana State University Health Sciences Center, New Orleans; Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, 2020 Gravier Street, Suite D, New Orleans, LA 70112 cchen{at}lsuhsc.edu
Lipids are essential components of plasma- and organelle-membranes, not only providing a frame for embedded proteins (e.g., receptors and ion channels) but also functioning as reservoirs for lipid mediators. Increasing evidence indicates that bioactive lipids such as eicosanoids, endocannabinoids, and lysophospholipids serve as intercellular and intracellular signaling molecules participating in physiological and pathological functions in the brain. The discovery of some of these lipid receptors and novel lipid signaling mediators has sparked an intense interest in lipidomic neurobiology research. Classic prostaglandins (PGD2, PGE2, PGF2 , PGI2, and TXA2), catalyzed by cyclooxygenases (COX), are synthesized from arachidonic acid (AA). Experimental studies demonstrate that prostaglandin E2 (PGE2), mainly derived from the COX-2 reaction, is an important mediator, acting as a retrograde messenger via a presynaptic PGE2 subtype 2 receptor (EP2) in modulation of synaptic events. Novel prostaglandins (prostaglandin glycerol esters and prostaglandin ethanolamides) are COX-2 oxidative metabolites of endogenous cannabinoids (2-arachidonyl glycerol and arachidonyl ethanolamide). Recent evidence suggests that these new types of prostaglandins are likely novel signaling mediators involved in synaptic transmission and plasticity. This means that COX- 2 plays a central role in metabolisms of AA and endocannabinoids (eCBs) and productions of AA- and eCB- derived prostaglandins. Thus, in the present review article, the authors will mainly discuss COX-2 regulation of prostaglandin signaling in modulation of hippocampal synaptic transmission and plasticity.
Key Words: Cyclooxygenases Prostaglandin E2 Endocannabinoids Prostaglandin glycerol esters Prostaglandin ethanolamides Long-term potentiation
The Neuroscientist, Vol. 12, No. 5,
425-434 (2006)
DOI: 10.1177/1073858406290794

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Zhang and C. Chen
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
J. Biol. Chem.,
August 15, 2008;
283(33):
22601 - 22611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Fogle, A. K. Lyashchenko, H. K. Turbendian, and G. R. Tibbs
HCN Pacemaker Channel Activation Is Controlled by Acidic Lipids Downstream of Diacylglycerol Kinase and Phospholipase A2
J. Neurosci.,
March 14, 2007;
27(11):
2802 - 2814.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|